Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Withdrawn 1Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 23Thoracic 3Breast 2Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 40Triple Negative Breast Neoplasms 34Carcinoma, Non-Small-Cell Lung 28Melanoma 18Ovarian Neoplasms 16Carcinoma, Renal Cell 16Neoplasm Metastasis 13Pancreatic Neoplasms 12Carcinoma, Transitional Cell 12Colorectal Neoplasms 11Stomach Neoplasms 9Squamous Cell Carcinoma of Head and Neck 9Neoplasms 9Uterine Cervical Neoplasms 7Lung Neoplasms 7Head and Neck Neoplasms 7Endometrial Neoplasms 7Carcinoma, Merkel Cell 7Carcinoma, Hepatocellular 7Small Cell Lung Carcinoma 6Prostatic Neoplasms 6Gastrointestinal Neoplasms 5Sarcoma 4Mesothelioma 4Urinary Bladder Neoplasms 3Lymphoma 3Hodgkin Disease 3Esophageal Neoplasms 3Cholangiocarcinoma 3Carcinoma, Ovarian Epithelial 3

Interventions

Nivolumab 2Cyclophosphamide 2tislelizumab 1spartalizumab 1pembrolizumab 1montanide ISA 51 1glembatumumab vedotin 1fludarabine phosphate 1entinostat 1cemiplimab 1Toll-Like Receptor 1 1Surveys and Questionnaires 1Specimen Handling 1Rose Bengal 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interleukin-2 1Interleukin-13 1Focus Groups 1Fluorodeoxyglucose F18 1Cryosurgery 1CTLA-4 Antigen 1CR011-vcMMAE 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uveal Melanoma × Nivolumab × Breast × Clear all
NCT04336241 2026-02-27

Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

Replimune, Inc.

Phase 1 Active not recruiting
36 enrolled
BreastDermatologicGastrointestinalThoracic

Uveal Melanoma, Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasms

NCT03326258 2018-07-18

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1/2 Withdrawn
BreastDermatologic

Uveal Melanoma, Breast Neoplasms, Melanoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡